Pharmaceutical Processing Equipment Market Size, Share, and COVID-19 Impact Analysis By Formulation (Oral Formulations, Topical Formulations, Parenteral Formulations, and Others), By Equipment (Tanks, Agitators, Mixers, Blenders, Capsule Equipment, High-Pressure Homogenizers, Tablet Press, Spray Coating Machines, and Others), and Regional Forecast, 2025-2032

The high quality of pharmaceutical products and their compliance with U.S. FDA regulations is majorly dependent on the quality of processing equipment used for manufacturing. This equipment plays a vital role in the manufacturing of pharmaceutical products. With the continuously evolving pharmaceutical industry, the need for flexible processing and advancements in manufacturing technologies, the market for pharmaceutical processing equipment has witnessed significant growth over the past few years. In addition, other factors propelling the market growth include increasing demand for pharmaceutical drugs, the growing trend of outsourcing, and the expansion of manufacturing capabilities by in-house as well as contract manufacturers.

• For instance, in January 2023, Dalton Pharma Services announced an expansion of its commercial sterile manufacturing capacity. This includes the installation of a new state-of-art, fully automated cGMP sterile filling line to support small-scale commercial manufacturing.

Furthermore, with the changing drug development trends, the manufacturing processes and equipment also change. To meet the growing market demand, and overcome the manufacturing challenges in the pharmaceutical industry, manufacturers are leveraging the latest technologies, such as digitalization, full automation, and others. However, the high price of this equipment and the high demand for refurbished equipment by small-scale manufacturers may impede market growth.

Impact of COVID-19 on the Pharmaceutical Processing Equipment Market

The COVID-19 pandemic had a positive impact on the pharmaceutical processing equipment market. During the pandemic, the market witnessed a high demand for therapeutic drugs to treat COVID-19 infection. Innovative manufacturing techniques helped drug manufacturers to expand their manufacturing capabilities during times of urgent requirement. This resulted in increased demand for pharmaceutical processing equipment among the vaccine and drug makers.

Key Insights

The report will cover the following key insights:

• Pharmaceutical Manufacturing Regulatory Framework, By Key Countries/Regions.
• Key Industry Developments -Mergers, Acquisitions and Partnerships.
• New Product Launches.
• Technological advancements in pharmaceutical manufacturing/processing.
• Impact of COVID-19 on the Global Pharmaceutical Processing Equipment Market.

Analysis by Formulation

The oral formulations segment is anticipated to capture the largest share of the global pharmaceutical processing equipment market. This is majorly attributed to the several benefits of oral drugs such as less painful administration, convenience, cost-effectiveness, and no requirement of skilled personnel for administration.  Moreover, the easy availability of oral formulations coupled with the higher preference of end-users towards the use of oral medications are some other factors that are expected to boost segment growth throughout the forecast period.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America accounted for the highest market share in the global pharmaceutical processing equipment market. The factors supplementing the dominance of the region include a high number of pharmaceutical manufacturers, a supportive regulatory framework, and a large number of strategic partnerships between drug manufacturers and equipment providers. In addition, the U.S. is the home to a large number of contract manufacturing service providers which further propels the regional market growth.

Key Players Covered

The report will include profiles of key players such as ACIC Pharmaceuticals Inc., IDEX, B&P Littleford, Lee Industries, KORSCH AG, KIKUSUI SEISAKUSHO LTD, M.A.R. S.p.A. Macchine Automatiche Riempitrici, Freund Corporation, and others.

Segmentation

Key Industry Developments

• January 2022: Alfa Laval introduced a new unique single-use separator range for single-use biopharma processing in lab scale to commercial scale production. This product eliminates the risk of cross-contamination and increases safety.
• June 2021: Siemens and BioNTech collaborated for the production of mRNA vaccine using end-to-end digitalized workflow. The availability of digital workflows and such collaborations would speed up the pharmaceutical processing.